白血球分离术市场 - 全球产业规模、份额、趋势、机会和预测，按类型、应用、最终用户、地区和竞争细分，2019-2029F

2023 年全球白血球去除术市场价值为7,652 万美元，预计在预测期内将稳定成长，到2029 年复合年增长率为5.25%。一直在经历显着增长、血液疾病盛行率不断上升，以及对个人化治疗的需求不断增长。白血球分离术是一种涉及从血液中分离白血球的医疗程序，在各种治疗应用中发挥着至关重要的作用，使其成为血液学和肿瘤学领域的关键参与者。全球白血球分离术市场涵盖广泛的技术、产品和应用，使其具有多样性和动态性。白血球分离术用于分离和收集白血球，主要是白血球，它们是免疫系统的重要组成部分。市场根据产品类型、应用、最终用户和地区进行细分。

市场概况
预测期	2025-2029
2023 年市场规模	7652万美元
2029 年市场规模	1.0426亿美元
2024-2029 年复合年增长率	5.25%
成长最快的细分市场	白血球分离装置
最大的市场	北美洲

主要市场驱动因素

血液疾病和血液癌症的发生率上升

越来越关注临床研究和药物开发

主要市场挑战

初始成本高且报销有限

主要市场趋势

技术进步

细分市场洞察

类型洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球白血球分离术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（白血球去除装置、单采装置、白血球去除柱、细胞分离器、白血球去除过滤器、白血球去除一次性用品）
  • 按应用（研究应用、治疗应用）
  • 按最终用户（血液成分提供者和血液中心、学术和研究机构、製药和生物技术公司、医院和输血中心）
  • 按地区
  • 按公司划分 (2023)
• 市场地图
  • 按类型
  • 按申请
  • 按最终用户
  • 按地区

第 6 章：北美白血球分离术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用户
  • 按国家/地区

第 7 章：欧洲白血球分离术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用户
  • 按国家/地区

第 8 章：亚太地区白血球分离术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用户
  • 按国家/地区

第 9 章：南美洲白血球分离术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用户
  • 按国家/地区

第 10 章：中东和非洲白血球去除术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用户
  • 按国家/地区

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第13章：竞争格局

• Asahi Kasei Medical Co. Ltd
• Haemonetics Corporation
• TERUMO BCT INC.
• STEMCELL Technologies Canada Inc.
• Fresenius SE & Co. KGaA
• B. Braun SE
• Caltag Medsystems Limited
• Precision Medicine Group, LLC
• Lmb Technologie GmbH
• Grifols, SA
• Kaneka Pharma Europe NV

第 14 章：策略建议

第15章调查会社について・免责事项

Global Leukapheresis Market was valued at USD 76.52 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The Global Leukapheresis Market has been experiencing significant growth in recent years, driven by advancements in healthcare technology, increasing prevalence of blood disorders, and a rising demand for personalized therapies. Leukapheresis, a medical procedure that involves separating white blood cells from blood, plays a crucial role in various therapeutic applications, making it a key player in the field of hematology and oncology. The global leukapheresis market encompasses a wide range of technologies, products, and applications, contributing to its diverse and dynamic nature. Leukapheresis procedures are employed for the isolation and collection of leukocytes, primarily white blood cells, which are essential components of the immune system. The market is segmented based on product types, applications, end-users, and regions.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 76.52 Million
Market Size 2029	USD 104.26 Million
CAGR 2024-2029	5.25%
Fastest Growing Segment	Leukapheresis Devices
Largest Market	North America

Key Market Drivers

Rising Incidence of Blood Disorders and Hematologic Cancers

In recent years, the global healthcare landscape has witnessed a notable surge in the incidence of blood disorders and hematologic cancers. This alarming trend has led to an increased demand for advanced therapeutic solutions, and one such technology gaining prominence is leukapheresis. Leukapheresis, a medical procedure that involves the separation and removal of white blood cells (leukocytes) from the blood, has become a critical component in the treatment of various hematologic conditions. As the prevalence of these disorders continues to rise, the global leukapheresis market is experiencing significant growth. Blood disorders and hematologic cancers encompass a broad spectrum of conditions, including leukemia, lymphoma, myeloma, and various anemias. The incidence of these disorders has been steadily increasing, placing a substantial burden on healthcare systems worldwide. Factors such as aging populations, exposure to environmental carcinogens, and genetic predispositions contribute to the rising prevalence of these diseases.

Leukapheresis is used to control elevated white blood cell counts in conditions like leukemia, preventing complications such as organ damage and clotting. For patients undergoing stem cell transplantation, leukapheresis is employed to collect healthy hematopoietic stem cells, which are essential for the restoration of the bone marrow and immune system. In certain autoimmune disorders, leukapheresis helps modulate the immune response by removing pathogenic white blood cells responsible for the autoimmune attack. Leukapheresis is also utilized in therapeutic plasma exchange, where plasma containing harmful antibodies or toxins is separated and replaced with a suitable substitute.

Growing Focus on Clinical Research and Drug Development

In recent years, the field of clinical research and drug development has experienced a significant surge in attention and investment. This heightened focus is primarily driven by the increasing prevalence of complex diseases and the need for innovative therapies. Within this landscape, the global leukapheresis market has emerged as a crucial player, providing essential tools and technologies to advance research and drug discovery processes. Immunotherapy has emerged as a revolutionary approach to treating various diseases by harnessing the body's immune system to target and eliminate abnormal cells. Leukapheresis is a crucial step in the development of immunotherapies, as it allows researchers to isolate immune cells, such as T cells, for genetic modification or activation before reintroducing them into the patient's body. The success of immunotherapeutic approaches, particularly in oncology, has propelled the demand for leukapheresis technologies.

The growing trend towards precision medicine and personalized therapies further underscores the importance of leukapheresis in clinical research. By isolating specific cell types from individual patients, researchers can tailor treatment strategies to the unique characteristics of each patient, enhancing treatment efficacy and minimizing adverse effects. This patient-centric approach is reshaping the drug development landscape and driving the adoption of leukapheresis technologies. Advancements in leukapheresis technologies have significantly enhanced their efficiency, precision, and scalability. Automated systems closed processing systems, and advanced separation techniques have streamlined the leukapheresis process, making it more accessible and reliable for large-scale clinical trials. These technological improvements are catalyzing the growth of the global leukapheresis market and empowering researchers to conduct more sophisticated studies.

Key Market Challenges

High Initial Costs and Limited Reimbursement

The significant challenges confronting the global leukapheresis market is the high initial costs associated with the technology and equipment required for the procedure. The implementation of advanced leukapheresis technologies, including automated systems and specialized devices, demands substantial financial investments. This poses a barrier for healthcare facilities, especially in developing regions, limiting their ability to adopt and integrate these technologies. The costs associated with leukapheresis equipment, disposable kits, and maintenance contribute to the financial burden on healthcare providers. Moreover, the need for skilled personnel to operate and manage these sophisticated systems adds to the overall expenses. As a result, smaller healthcare facilities and those with limited budgets may find it challenging to embrace the latest leukapheresis technologies, hindering the market's growth potential. In addition to high initial costs, the limited reimbursement options for leukapheresis procedures pose a substantial challenge for both healthcare providers and patients. Reimbursement policies vary across regions, and in some cases, the reimbursement rates may not adequately cover the costs associated with leukapheresis. This creates a financial strain on healthcare facilities and may deter them from offering these procedures. The lack of standardized reimbursement models for leukapheresis can lead to disparities in access to this critical medical intervention. Patients may face difficulties in obtaining insurance coverage for leukapheresis treatments, limiting their ability to benefit from the procedure. This not only affects the overall adoption of leukapheresis but also exacerbates healthcare inequalities, as access to advanced medical interventions becomes contingent on financial means.

Key Market Trends

Technological Advancements

In recent years, the field of healthcare has witnessed an unprecedented surge in technological advancements, leading to groundbreaking innovations and transformative changes. One such area that has benefited immensely from these advancements is the Global Leukapheresis Market. Leukapheresis, a medical procedure involving the separation and collection of white blood cells (leukocytes) from the blood, plays a crucial role in various therapeutic and diagnostic applications. The integration of cutting-edge technologies has not only enhanced the efficiency and precision of leukapheresis procedures but has also opened up new avenues for therapeutic advancements. The incorporation of automation and robotics has significantly streamlined the leukapheresis process. Automated systems can perform procedures with high precision, reducing the risk of manual errors. This not only ensures a higher quality of collected cells but also enhances the overall efficiency of the procedure, allowing healthcare professionals to focus on patient care.

Technological advancements in cell separation techniques have revolutionized the isolation of specific cell populations during leukapheresis. Novel methods, such as microfluidics and advanced filtration systems, enable a more targeted and efficient collection of white blood cells. This level of precision is crucial in applications like stem cell transplantation and immunotherapy. Artificial intelligence has found its way into leukapheresis technologies, offering predictive analytics and real-time monitoring capabilities. AI algorithms can analyze data during the procedure, optimizing parameters for cell collection and minimizing potential side effects. This not only improves the safety profile of leukapheresis but also enhances its efficacy. Apheresis devices, the cornerstone of leukapheresis, have evolved significantly. Next-generation devices offer improved scalability, allowing for increased throughput and faster procedures. Moreover, these devices often come equipped with user-friendly interfaces and connectivity features, facilitating seamless integration into healthcare systems. Technological advancements in cell processing have led to the development of closed-system platforms, reducing the risk of contamination and ensuring the sterility of collected cells. Additionally, these advancements enable the manipulation and modification of collected cells for therapeutic purposes, contributing to the expanding field of personalized medicine.

Segmental Insights

Type Insights

Based on the category of type, Leukapheresis Devices emerged as the dominant segment in the global market for Leukapheresis in 2023. Leukapheresis devices have seen substantial technological advancements, enabling more precise and efficient cell separation. Innovations such as continuous flow centrifugation and closed-system processing have enhanced the safety and effectiveness of the leukapheresis procedure. The increasing prevalence of blood-related disorders, such as leukemia and lymphoma, has led to a surge in the demand for leukapheresis procedures. Leukapheresis devices have become indispensable in the collection of white blood cells for subsequent therapeutic applications, such as stem cell transplantation. The rise of cell-based therapies, including chimeric antigen receptor T-cell (CAR-T) therapy, has further propelled the demand for leukapheresis devices. These devices play a pivotal role in collecting and isolating the patient's immune cells for the development of personalized and targeted therapies.

Regional Insights

North America emerged as the dominant region in the global Leukapheresis market in 2023, holding the largest market share in terms of value. North America boasts a robust healthcare infrastructure and is at the forefront of technological advancements in medical procedures. The region has witnessed continuous innovation in leukapheresis technologies, leading to improved efficiency, safety, and patient outcomes. The adoption of automated systems and advanced cell separation techniques has positioned North American companies as leaders in the global market. The prevalence of blood disorders, including leukemia, has been on the rise globally. North America, with a large and aging population, has experienced a growing demand for therapeutic interventions such as leukapheresis. The region's proactive approach to healthcare, coupled with a high awareness of blood-related diseases, has fueled the demand for leukapheresis procedures.

Key Market Players

Asahi Kasei Medical Co. Ltd

Haemonetics Corporation

TERUMO BCT INC.

STEMCELL Technologies Canada Inc.

Fresenius SE & Co. KGaA

B. Braun SE

Caltag Medsystems Limited

Precision Medicine Group, LLC

Lmb Technologie GmbH

Grifols, S.A

Kaneka Pharma Europe NV

Report Scope:

In this report, the Global Leukapheresis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Leukapheresis Market, By Type:

Leukapheresis Devices Apheresis Devices Leukapheresis Columns Cell Separators Leukoreduction Filters Leukapheresis Disposables

Leukapheresis Market, By Application:

Research Applications Therapeutic Applications

Leukapheresis Market, By End User:

Blood Component Providers and Blood Centers Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Transfusion Centers

Leukapheresis Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Leukapheresis Market.

Available Customizations:

Global Leukapheresis market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Leukapheresis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Leukapheresis Devices, Apheresis Devices, Leukapheresis Columns, Cell Separators, Leukoreduction Filters, Leukapheresis Disposables)
  • 5.2.2. By Application (Research Applications, Therapeutic Applications)
  • 5.2.3. By End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Leukapheresis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
    • 6.2.4.1. United States Leukapheresis Market Outlook
      • 6.2.4.1.1. Market Size & Forecast
      • 6.2.4.1.1.1. By Value
      • 6.2.4.1.2. Market Share & Forecast
      • 6.2.4.1.2.1. By Type
      • 6.2.4.1.2.2. By Application
      • 6.2.4.1.2.3. By End User
    • 6.2.4.2. Canada Leukapheresis Market Outlook
      • 6.2.4.2.1. Market Size & Forecast
      • 6.2.4.2.1.1. By Value
      • 6.2.4.2.2. Market Share & Forecast
      • 6.2.4.2.2.1. By Type
      • 6.2.4.2.2.2. By Application
      • 6.2.4.2.2.3. By End User
    • 6.2.4.3. Mexico Leukapheresis Market Outlook
      • 6.2.4.3.1. Market Size & Forecast
      • 6.2.4.3.1.1. By Value
      • 6.2.4.3.2. Market Share & Forecast
      • 6.2.4.3.2.1. By Type
      • 6.2.4.3.2.2. By Application
      • 6.2.4.3.2.3. By End User

7. Europe Leukapheresis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
    • 7.2.4.1. France Leukapheresis Market Outlook
      • 7.2.4.1.1. Market Size & Forecast
      • 7.2.4.1.1.1. By Value
      • 7.2.4.1.2. Market Share & Forecast
      • 7.2.4.1.2.1. By Type
      • 7.2.4.1.2.2. By Application
      • 7.2.4.1.2.3. By End User
    • 7.2.4.2. Germany Leukapheresis Market Outlook
      • 7.2.4.2.1. Market Size & Forecast
      • 7.2.4.2.1.1. By Value
      • 7.2.4.2.2. Market Share & Forecast
      • 7.2.4.2.2.1. By Type
      • 7.2.4.2.2.2. By Application
      • 7.2.4.2.2.3. By End User
    • 7.2.4.3. United Kingdom Leukapheresis Market Outlook
      • 7.2.4.3.1. Market Size & Forecast
      • 7.2.4.3.1.1. By Value
      • 7.2.4.3.2. Market Share & Forecast
      • 7.2.4.3.2.1. By Type
      • 7.2.4.3.2.2. By Application
      • 7.2.4.3.2.3. By End User
    • 7.2.4.4. Italy Leukapheresis Market Outlook
      • 7.2.4.4.1. Market Size & Forecast
      • 7.2.4.4.1.1. By Value
      • 7.2.4.4.2. Market Share & Forecast
      • 7.2.4.4.2.1. By Type
      • 7.2.4.4.2.2. By Application
      • 7.2.4.4.2.3. By End User
    • 7.2.4.5. Spain Leukapheresis Market Outlook
      • 7.2.4.5.1. Market Size & Forecast
      • 7.2.4.5.1.1. By Value
      • 7.2.4.5.2. Market Share & Forecast
      • 7.2.4.5.2.1. By Type
      • 7.2.4.5.2.2. By Application
      • 7.2.4.5.2.3. By End User

8. Asia Pacific Leukapheresis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
    • 8.2.4.1. China Leukapheresis Market Outlook
      • 8.2.4.1.1. Market Size & Forecast
      • 8.2.4.1.1.1. By Value
      • 8.2.4.1.2. Market Share & Forecast
      • 8.2.4.1.2.1. By Type
      • 8.2.4.1.2.2. By Application
      • 8.2.4.1.2.3. By End User
    • 8.2.4.2. India Leukapheresis Market Outlook
      • 8.2.4.2.1. Market Size & Forecast
      • 8.2.4.2.1.1. By Value
      • 8.2.4.2.2. Market Share & Forecast
      • 8.2.4.2.2.1. By Type
      • 8.2.4.2.2.2. By Application
      • 8.2.4.2.2.3. By End User
    • 8.2.4.3. South Korea Leukapheresis Market Outlook
      • 8.2.4.3.1. Market Size & Forecast
      • 8.2.4.3.1.1. By Value
      • 8.2.4.3.2. Market Share & Forecast
      • 8.2.4.3.2.1. By Type
      • 8.2.4.3.2.2. By Application
      • 8.2.4.3.2.3. By End User
    • 8.2.4.4. Japan Leukapheresis Market Outlook
      • 8.2.4.4.1. Market Size & Forecast
      • 8.2.4.4.1.1. By Value
      • 8.2.4.4.2. Market Share & Forecast
      • 8.2.4.4.2.1. By Type
      • 8.2.4.4.2.2. By Application
      • 8.2.4.4.2.3. By End User
    • 8.2.4.5. Australia Leukapheresis Market Outlook
      • 8.2.4.5.1. Market Size & Forecast
      • 8.2.4.5.1.1. By Value
      • 8.2.4.5.2. Market Share & Forecast
      • 8.2.4.5.2.1. By Type
      • 8.2.4.5.2.2. By Application
      • 8.2.4.5.2.3. By End User

9. South America Leukapheresis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
    • 9.2.4.1. Brazil Leukapheresis Market Outlook
      • 9.2.4.1.1. Market Size & Forecast
      • 9.2.4.1.1.1. By Value
      • 9.2.4.1.2. Market Share & Forecast
      • 9.2.4.1.2.1. By Type
      • 9.2.4.1.2.2. By Application
      • 9.2.4.1.2.3. By End User
    • 9.2.4.2. Argentina Leukapheresis Market Outlook
      • 9.2.4.2.1. Market Size & Forecast
      • 9.2.4.2.1.1. By Value
      • 9.2.4.2.2. Market Share & Forecast
      • 9.2.4.2.2.1. By Type
      • 9.2.4.2.2.2. By Application
      • 9.2.4.2.2.3. By End User
    • 9.2.4.3. Colombia Leukapheresis Market Outlook
      • 9.2.4.3.1. Market Size & Forecast
      • 9.2.4.3.1.1. By Value
      • 9.2.4.3.2. Market Share & Forecast
      • 9.2.4.3.2.1. By Type
      • 9.2.4.3.2.2. By Application
      • 9.2.4.3.2.3. By End User

10. Middle East & Africa Leukapheresis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
    • 10.2.4.1. South Africa Leukapheresis Market Outlook
      • 10.2.4.1.1. Market Size & Forecast
      • 10.2.4.1.1.1. By Value
      • 10.2.4.1.2. Market Share & Forecast
      • 10.2.4.1.2.1. By Type
      • 10.2.4.1.2.2. By Application
      • 10.2.4.1.2.3. By End User
    • 10.2.4.2. Saudi Arabia Leukapheresis Market Outlook
      • 10.2.4.2.1. Market Size & Forecast
      • 10.2.4.2.1.1. By Value
      • 10.2.4.2.2. Market Share & Forecast
      • 10.2.4.2.2.1. By Type
      • 10.2.4.2.2.2. By Application
      • 10.2.4.2.2.3. By End User
    • 10.2.4.3. UAE Leukapheresis Market Outlook
      • 10.2.4.3.1. Market Size & Forecast
      • 10.2.4.3.1.1. By Value
      • 10.2.4.3.2. Market Share & Forecast
      • 10.2.4.3.2.1. By Type
      • 10.2.4.3.2.2. By Application
      • 10.2.4.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Asahi Kasei Medical Co. Ltd
  • 13.1.1. Business Overview
  • 13.1.2. Product & Service Offerings
  • 13.1.3. Financials (If Listed)
  • 13.1.4. Recent Developments
  • 13.1.5. Key Personnel
  • 13.1.6. SWOT Analysis
• 13.2. Haemonetics Corporation
• 13.3. TERUMO BCT INC.
• 13.4. STEMCELL Technologies Canada Inc.
• 13.5. Fresenius SE & Co. KGaA
• 13.6. B. Braun SE
• 13.7. Caltag Medsystems Limited
• 13.8. Precision Medicine Group, LLC
• 13.9. Lmb Technologie GmbH
• 13.10. Grifols, S.A
• 13.11. Kaneka Pharma Europe NV

14. Strategic Recommendations

15. About us & Disclaimer